Ketorolac Kabi Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

ketorolac kabi

fresenius kabi new zealand limited - ketorolac trometamol 30 mg/ml - solution for injection - 30 mg/ml - active: ketorolac trometamol 30 mg/ml excipient: ethanol hydrochloric acid sodium chloride sodium hydroxide water for injection - ketorolac kabi is indicated for the short-term management of moderately severe, acute pain following surgical procedures. the total duration of ketorolac use should not exceed five days. it is recommended that ketorolac parenteral be used in the immediate post-operative period. patients can then be converted to the oral* formulation (dependent on their analgesic needs), as outlined in section 4.2 dose and method of administration (conversion from intramuscular to oral therapy). the total period of treatment utilising the oral and/or intramuscular route of administration is not to exceed five days. * ketorolac oral formulation is available from other brands. ketorolac is not recommended for use as an obstetrical pre-operative medication or for obstetrical analgesia because it has not been adequately studied for use in these circumstances and because the known effects of drugs that inhibit prostaglandin biosynthesis on uterine contraction and foetal circulation. there is no satisfactory evidence for the use of ketorolac in acute exacerbations of chronic painful inflammatory conditions (e.g. rheumatoid or osteoarthritis).

SmofKabiven NTense Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

smofkabiven ntense

fresenius kabi new zealand limited - alanine 14 g/l;  ;  ; arginine 12 g/l;  ;  ; calcium chloride dihydrate 0.574 g/l equivalent to calcium chloride 0.434 g/l;  ; glycine 11 g/l;  ;  ;  ; histidine 3 g/l;  ;  ;  ; isoleucine 5 g/l;  ;  ;  ; leucine 7.4 g/l;  ;  ;  ; lysine acetate 9.3 g/l equivalent to l-lysine 6.6 g/l;  ;  ; magnesium sulfate heptahydrate 1.92 g/l equivalent to magnesium sulfate 0.931 g/l;  ; methionine 4.3 g/l;  ;  ; phenylalanine 5.1 g/l;  ;  ; potassium chloride 3.48 g/l;  ; proline 11.2 g/l;  ; serine 6.5 g/l;  ;  ;  ; sodium acetate trihydrate 4.1 g/l equivalent to sodium acetate 2.47 g/l;  ;  ;  ; sodium glycerophosphate 3.48 g/l; sodium glycerophosphate hydrate equivalent to sodium glycerophosphate 3.48 g/l;  ; taurine 1 g/l;  ; threonine 4.4 g/l;  ;  ;  ; tryptophan 2 g/l;  ;  ; tyrosine 0.4 g/l;  ; valine 6.2 g/l;  ;  ;  ;  ; zinc sulfate heptahydrate 0.0178 g/l equivalent to zinc sulfate 0.0100 g/l;  ; glucose monohydrate 462 g/l equivalent to to glucose 420 g/l;  ;  ; fish oil 30 g/l; medium-chain triglycerides 60 g/l;  ; olive oil 50 g/l;  ; soya oil 60 g/l;   - emulsion for infusion - active: alanine 14 g/l     arginine 12 g/l     calcium chloride dihydrate 0.574 g/l equivalent to calcium chloride 0.434 g/l   glycine 11 g/l       histidine 3 g/l       isoleucine 5 g/l       leucine 7.4 g/l       lysine acetate 9.3 g/l equivalent to l-lysine 6.6 g/l     magnesium sulfate heptahydrate 1.92 g/l equivalent to magnesium sulfate 0.931 g/l   methionine 4.3 g/l     phenylalanine 5.1 g/l     potassium chloride 3.48 g/l   proline 11.2 g/l   serine 6.5 g/l       sodium acetate trihydrate 4.1 g/l equivalent to sodium acetate 2.47 g/l       sodium glycerophosphate 3.48 g/l sodium glycerophosphate hydrate equivalent to sodium glycerophosphate 3.48 g/l   taurine 1 g/l   threonine 4.4 g/l       tryptophan 2 g/l     tyrosine 0.4 g/l   valine 6.2 g/l         zinc sulfate heptahydrate 0.0178 g/l equivalent to zinc sulfate 0.0100 g/l   excipient: glacial acetic acid nitrogen water for injection active: glucose monohydrate 462 g/l equivalent to to glucose 420 g/l     excipient: hydrochloric acid nitrogen water for injection active: fish oil 30 g/l medium-chain triglycerides 60 g/l   olive oil 50 g/l   soya oil 60 g/l   excipient: egg lecithin glycerol nitrogen sodium hydroxide sodium oleate tocoferols water for injection - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.

SmofKabiven Low Osmo Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

smofkabiven low osmo

fresenius kabi new zealand limited - alanine 14 g/l;  ;  ; arginine 12 g/l;  ;  ; calcium chloride dihydrate 0.74 g/l equivalent to calcium chloride 0.56 g/l;  ; glycine 11 g/l;  ;  ;  ; histidine 3 g/l;  ;  ;  ; isoleucine 5 g/l;  ;  ;  ; leucine 7.4 g/l;  ;  ;  ; lysine acetate 9.3 g/l equivalent to l-lysine 6.6 g/l;  ;  ; magnesium sulfate heptahydrate 2.47 g/l equivalent to magnesium sulfate 1.2 g/l;  ; methionine 4.3 g/l;  ;  ; phenylalanine 5.1 g/l;  ;  ; potassium chloride 4.48 g/l;  ; proline 11.2 g/l;  ; serine 6.5 g/l;  ;  ;  ; sodium acetate trihydrate 5.62 g/l equivalent to sodium acetate 3.4 g/l;  ;  ;  ; sodium glycerophosphate 4.18 g/l; sodium glycerophosphate hydrate equivalent to sodium glycerophosphate 4.18g/l;  ; taurine 1 g/l;  ; threonine 4.4 g/l;  ;  ;  ; tryptophan 2 g/l;  ;  ; tyrosine 0.4 g/l;  ; valine 6.2 g/l;  ;  ;  ;  ; zinc sulfate heptahydrate 0.023 g/l equivalent to zinc sulfate 0.0129 g/l;  ; glucose monohydrate 130 g/l equivalent to glucose 118 g/l;  ;  ; fish oil 30 g/l; medium-chain triglycerides 60 g/l;  ; olive oil 50 g/l;  ; soya oil 60 g/l;   - emulsion for infusion - active: alanine 14 g/l     arginine 12 g/l     calcium chloride dihydrate 0.74 g/l equivalent to calcium chloride 0.56 g/l   glycine 11 g/l       histidine 3 g/l       isoleucine 5 g/l       leucine 7.4 g/l       lysine acetate 9.3 g/l equivalent to l-lysine 6.6 g/l     magnesium sulfate heptahydrate 2.47 g/l equivalent to magnesium sulfate 1.2 g/l   methionine 4.3 g/l     phenylalanine 5.1 g/l     potassium chloride 4.48 g/l   proline 11.2 g/l   serine 6.5 g/l       sodium acetate trihydrate 5.62 g/l equivalent to sodium acetate 3.4 g/l       sodium glycerophosphate 4.18 g/l sodium glycerophosphate hydrate equivalent to sodium glycerophosphate 4.18g/l   taurine 1 g/l   threonine 4.4 g/l       tryptophan 2 g/l     tyrosine 0.4 g/l   valine 6.2 g/l         zinc sulfate heptahydrate 0.023 g/l equivalent to zinc sulfate 0.0129 g/l   excipient: acetic acid nitrogen water for injection active: glucose monohydrate 130 g/l equivalent to glucose 118 g/l     excipient: nitrogen water for injection active: fish oil 30 g/l medium-chain triglycerides 60 g/l   olive oil 50 g/l   soya oil 60 g/l   excipient: egg lecithin glycerol nitrogen sodium hydroxide sodium oleate tocoferols water for injection - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated

Intralipid Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

intralipid

fresenius kabi new zealand limited - soya oil 10%{relative};  ;   - solution for infusion - 10 % - active: soya oil 10%{relative}     excipient: egg lecithin glycerol water for injection - part of the intravenous diet in all parenteral nutrition indications including: - preoperative and postoperative nutritional disturbances where an improved nitrogen balance is required; - nutritional disorders or disturbances of nitrogen balance due to inadequate or failing intestinal absorption caused by tumours in the gastrointestinal tract, acute or chronic intestinal diseases (peritonitis, ulcerative colitis, terminal ileitis); - burns, to reduce the frequently excessive nitrogen losses; - prolonged unconsciousness, eg following cranial trauma or poisoning in cases where enteral feeding is inappropriate or impossible; - impaired renal function where a concentrated source of energy may be indicated to reduce protein breakdown; - cachexia and - patients with essential fatty acid deficiency who cannot maintain or restore a normal essential fatty acid pattern by oral intake.

Moxifloxacin Kabi Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

moxifloxacin kabi

fresenius kabi new zealand limited - moxifloxacin hydrochloride 1.75 mg/ml equivalent to moxifloxacin 1.6mg/ml;   - solution for infusion - active: moxifloxacin hydrochloride 1.75 mg/ml equivalent to moxifloxacin 1.6mg/ml   excipient: sodium acetate trihydrate sodium sulfate sulfuric acid water for injection - indicated for the treatment of the following bacterial infections caused by susceptible strains: - pneumonia (community acquired)

Piperacillin/Tazobactam Kabi Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

piperacillin/tazobactam kabi

fresenius kabi new zealand limited - piperacillin sodium 2.085 g equivalent to piperacillin 2g; tazobactam sodium 0.2683 g equivalent to tazobactam 0.25g - powder for injection - active: piperacillin sodium 2.085 g equivalent to piperacillin 2g tazobactam sodium 0.2683 g equivalent to tazobactam 0.25g - piperacillin/ tazobactam is indicated for the treatment of the following systemic and/or local bacterial infections in which susceptible organisms have been detected or are suspected: 1. lower respiratory tract infections 2. urinary tract infections (complicated and uncomplicated) 3. intra-abdominal infections 4. skin and skin structure infections 5. bacterial septicaemia 6. gynaecological infections 7. bacterial infections in neutropenic patients. full therapeutic doses of piperacillin/ tazobactam kabi plus an aminoglycoside should be used. 8. bone and joint infections 9. polymicrobic infections: piperacillin/tazobactam kabi is indicated for polymicrobic infections including those where aerobic and anaerobic organisms are suspected (intra-abdominal, skin and skin structure, upper and lower respiratory tract, gynaecological). children under the age of 12 years: in hospitalised children aged 2 to 12 years, piperacillin/ tazobactam is indicated for the treatment of serious intra-abdominal infections.

Piperacillin/Tazobactam Kabi Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

piperacillin/tazobactam kabi

fresenius kabi new zealand limited - piperacillin sodium 4.17 g equivalent to piperacillin 4g; tazobactam sodium 0.5366 g equivalent to tazobactam 0.5g - powder for injection - active: piperacillin sodium 4.17 g equivalent to piperacillin 4g tazobactam sodium 0.5366 g equivalent to tazobactam 0.5g - piperacillin/ tazobactam is indicated for the treatment of the following systemic and/or local bacterial infections in which susceptible organisms have been detected or are suspected: 1. lower respiratory tract infections 2. urinary tract infections (complicated and uncomplicated) 3. intra-abdominal infections 4. skin and skin structure infections 5. bacterial septicaemia 6. gynaecological infections 7. bacterial infections in neutropenic patients. full therapeutic doses of piperacillin/ tazobactam kabi plus an aminoglycoside should be used. 8. bone and joint infections 9. polymicrobic infections: piperacillin/tazobactam kabi is indicated for polymicrobic infections including those where aerobic and anaerobic organisms are suspected (intra-abdominal, skin and skin structure, upper and lower respiratory tract, gynaecological). children under the age of 12 years: in hospitalised children aged 2 to 12 years, piperacillin/ tazobactam is indicated for the treatment of serious intra-abdominal infections.

Ondansetron Kabi Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

ondansetron kabi

fresenius kabi new zealand limited - ondansetron hydrochloride dihydrate 2.5 mg/ml equivalent to ondansetron 2 mg/ml;   - solution for injection - 2 mg/ml - active: ondansetron hydrochloride dihydrate 2.5 mg/ml equivalent to ondansetron 2 mg/ml   excipient: citric acid monohydrate sodium chloride sodium citrate dihydrate water for injection - ondansetron injection is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. ondansetron injection is also indicated for the prevention and treatment of post-operative nausea and vomiting.

Structolipid 20% Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

structolipid 20%

fresenius kabi new zealand limited - structured triglycerides 200 g/l (64:36 ratio of long chain:medium chain triglycerides);  ;   - emulsion for infusion - 20% w/v - active: structured triglycerides 200 g/l (64:36 ratio of long chain:medium chain triglycerides)     excipient: egg lecithin glycerol nitrogen sodium hydroxide water for injection

SmofKabiven Australien - engelska - Department of Health (Therapeutic Goods Administration)

smofkabiven

fresenius kabi australia pty limited - olive oil; magnesium sulfate heptahydrate; lysine acetate; soya oil; alanine; histidine; calcium chloride; glycine; methionine; sodium acetate trihydrate; fish oil - rich in omega-3 acids; sodium glycerophosphate; zinc sulfate heptahydrate; tryptophan; threonine; valine; isoleucine; medium chain triglycerides; phenylalanine; glucose - anhydrous; tyrosine; arginine; leucine; taurine; serine; proline; potassium chloride -